First synthesis of indirubin N-glycosides (red sugars)

Tetrahedron Letters

Volumn 47, Issue 38, 2006, Pages 6907-6909

  Libnow, Stefanie ^a   Hein, Martin ^a   Michalik, Dirk ^b   Langer, Peter ^a,b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b LEIBNIZ INSTITUT FÜR KATALYSE E V AN DER UNIVERSITÄT ROSTOCK   (Germany)

Author keywords

Indirubin; N Glycosides; N Glycosyl anilines; N Glycosyl isatines; N Heterocycles

Indexed keywords

ACETIC ACID DERIVATIVE; GLYCOSIDE; N (BETA DEXTRO GALACTOPYRANOSYL)INDIRUBIN; N (BETA DEXTRO MANNOPYRANOSYL)INDIRUBIN; N (BETA DEXTRO RHAMNOPYRANOSYL)INDIRUBIN; N (BETA DEXTRO RIBOPYRANOSYL)INDIRUBIN; N (BETA LEVO RHAMNOPYRANOSYL)INDIRUBIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL PROCEDURES; CHEMICAL REACTION; DRUG SYNTHESIS; REACTION ANALYSIS;

EID: 33747192579     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2006.07.024     Document Type: Article

References (20)

1. Review:. Gribble G., and Berthel S. Studies in Natural Products Chemistry Vol. 12 (1993), Elsevier Science, New York 365-409
2. Isolation of staurosporin:. Omura S., Iwai Y., Hirano A., Nakagawa A., Awaya J., Tsuchiya H., Takahashi Y., and Masuma R. J. Antibiot. 30 (1977) 275-282
3. synthesis:. Link J.T., Raghavan S., Gallant M., Danishefsky S.J., Chou T.C., and Ballas L.M. J. Am. Chem. Soc. 118 (1996) 2825-2842
4. pharmacological activity:. Yamashita Y., Fujii N., Murakata C., Ashizawa T., Okabe M., and Nakano H. Biochemistry 31 (1992) 12069-12075
5. Hein M., Michalik D., and Langer P. Synthesis 20 (2005) 3531-3534
6. Hein M., Nguyen T.B.P., Michalik D., Görls H., Lalk M., and Langer P. Tetrahedron Lett. 47 (2006) 5741
7. Maskey R.P., Grün-Wollny I., Fiebig H.H., and Laatsch H. Angew. Chem. 114 (2002) 623-625
8. Angew. Chem., Int. Ed. 41 (2002) 597-599
9. Sassatelli M., Saab E., Anizon F., Prudhomme M., and Moreau P. Tetrahedron Lett. 45 (2004) 4827-4830
10. Sassatelli M., Bouchikhi F., Messaoudi S., Anizon F., Debiton E., Barthomeuf C., Prudhomme M., and Moreau P. Eur. J. Med. Chem. 41 (2006) 88-100
11. Moon M.J., Lee S.K., Lee J.-W., Song W.K., Kim S.W., Kim J.I., Cho C., Choi S.J., and Kim Y.-C. Bioorg. Med. Chem. 14 (2006) 237-246
12. Indirubin, the red shade of indigo. In Life in Progress; Meijer, L., Guyard, N., Skaltsounis, L. A., Eisenbrand, G., Ed.; Station Biologique, Roscoff, in press.
13. Chavis C., De Gourcy C., Dumont F., and Imbach J.-L. Carbohydr. Res. 113 (1983) 1-20
14. Douglas J.G., and Honeyman J. J. Chem. Soc. (1955) 3674-3680
15. Preobrazhenskaya M.N., Yartseva I.V., and Ektova L.V. Nucleic Acid Chem. 2 (1978) 725-727
16. Yartseva I.V., Ektova L.V., and Preobrazhenskaya M.N. Bioorg. Khim. 1 (1975) 189-194
17. 11 N-(2,3,4,6-tetra-O-acetyl-β-d-galactopyranosyl)isatine and N-(2,3,4,6-tetra-O-acetyl-β-d-mannopyranosyl)isatine were carried out following the procedure as described above. In contrast, isomerically enriched β-anomers (β/α >5:1) were employed as starting materials. Starting with N-(2,3,4,6-tetra-O-acetyl-α,β-d-glucopyranosyl)aniline (1.00 g, 2.36 mmol), N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)isatine was isolated (0.34 g, 30%). N-(2,3,4-Tri-O-acetyl-α,β-d-ribopyranosyl)aniline (0.75 g, 2.13 mmol) was transformed into N-(2,3,4-tri-O-acetyl-β-d-ribopyranosyl)isatine (0.18 g, 21%). Starting with N-(2,3,4,6-tetra-O-acetyl-α,β-d-galactopyranosyl)aniline (0.80 g, 1.89 mmol), N-(2,3,4,6-tetra-O-acetyl-β-d-galactopyranosyl)isatine was isolated (0.47 g, 52%). N-(2,3,4,6-Tetra-O-acetyl-α,β-d-mannopyranosyl)aniline (1.00 g, 2.36 mmol) was transformed into N-(2,3,4,6-tetra-O-acetyl-β-d-mannopyranosyl)isatine (0.24 g, 21%). All products were purified by column chromatography (heptane/EtOAc = 2:1).
18. Russell G.A., and Kaupp G. J. Am. Chem. Soc. 91 (1969) 3851-3859
19. Polychronopoulos P., Magiatis P., Skaltsounis A.-L., Myrianthopoulos V., Mikros E., Tarricone A., Musacchio A., Roe S.M., Pearl L., Leost M., Greengard P., and Meijer L. J. Med. Chem. 47 (2004) 935-946
20. 3-MeOH, 20:1→10:1) yielded 9β (100 mg, 59%).